Clinical trial
Respiratory Microbiome and COPD Exacerbations
NCT03432234 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Respiratory Microbiome and COPD Exacerbations
- Lead sponsor
- Corporacion Parc Tauli
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 7, 2016
- Completion date
- December 31, 2020
- Enrollment
- 120 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
exacerbation copd, pulmonary disease, chronic obstructive